Common Contracts

ShangPharma Corporation [5,800,000] American Depositary Shares Representing [104,400,000] Ordinary Shares (Par Value US$0.001 Per Share) Underwriting Agreement

ShangPharma Corp • October 15th, 2010 • Pharmaceutical preparations

• Company
  ShangPharma Corp
• Filed
  October 15th, 2010
• Industry
  Pharmaceutical preparations

ShangPharma Corporation, an exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [3,200,000] American Depositary Shares (“ADSs”), representing [57,600,000] ordinary shares, par value US$0.001 per share, of the Company (the “Ordinary Shares”), and certain shareholders of the Company named in Schedule 2 hereto (the “Selling Shareholders”) propose to sell to the several Underwriters an aggregate of [2,600,000] ADSs representing [46,800,000] Ordinary Shares (collectively, the “Underwritten ADSs”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [870,000] ADSs representing [15,600,000] Ordinary Shares of the Company (collectively, the “Option ADSs”). The Underwritten ADSs and the Option ADSs are

Trony Solar Holdings Company Limited American Depositary Shares Representing Ordinary Shares Underwriting Agreement

Trony Solar Holdings Co LTD • December 8th, 2009 • Semiconductors & related devices • New York

• Company
  Trony Solar Holdings Co LTD
• Filed
  December 8th, 2009
• Industry
  Semiconductors & related devices
• Jurisdiction
  New York

Trony Solar Holdings Company Limited, an exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of American Depositary Shares (“ADSs”), representing ordinary shares, par value US$0.0001 per share, of the Company (the “Ordinary Shares”), and certain shareholders of the Company named in Schedule 2 hereto (the “Selling Shareholders”) propose to sell to the several Underwriters an aggregate of ADSs, representing Ordinary Shares (collectively, the “Underwritten ADSs”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional ADSs, representing additional Ordinary Shares (collectively, the “Option ADSs”). The Underwritten ADSs and the Option ADSs that the Underwriters elect to purchase pursuant to Section 2 hereo